Ketohexokinase, the central fructose-metabolizing enzyme in heart, is shown to be alternatively spliced during pathological cardiac hypertrophy by the splicing factor 3b subunit 1 (SF3B1) (Mirtschink et al., 2015). This evidence concerns the gene SF3B1 and cardiac hypertrophy.